The Fort Worth Press - US researchers seek to legitimize AI mental health care

USD -
AED 3.672498
AFN 66.278316
ALL 82.286767
AMD 381.405623
ANG 1.790403
AOA 917.00002
ARS 1450.564198
AUD 1.514417
AWG 1.8
AZN 1.697242
BAM 1.668053
BBD 2.013416
BDT 122.25212
BGN 1.66944
BHD 0.37697
BIF 2955.517555
BMD 1
BND 1.290672
BOB 6.907492
BRL 5.527305
BSD 0.999672
BTN 90.191513
BWP 13.210404
BYN 2.933001
BYR 19600
BZD 2.010516
CAD 1.379755
CDF 2263.999888
CHF 0.795601
CLF 0.023236
CLP 911.550398
CNY 7.04125
CNH 7.036685
COP 3863.71
CRC 498.08952
CUC 1
CUP 26.5
CVE 94.043045
CZK 20.766403
DJF 178.015071
DKK 6.37969
DOP 62.81557
DZD 129.63396
EGP 47.590799
ERN 15
ETB 155.468002
EUR 0.8539
FJD 2.283699
FKP 0.746974
GBP 0.747803
GEL 2.68995
GGP 0.746974
GHS 11.495998
GIP 0.746974
GMD 73.501218
GNF 8739.594705
GTQ 7.656257
GYD 209.143749
HKD 7.780745
HNL 26.330401
HRK 6.432501
HTG 130.92649
HUF 330.323966
IDR 16735.5
ILS 3.210505
IMP 0.746974
INR 89.672804
IQD 1309.515179
IRR 42125.000006
ISK 126.029813
JEP 0.746974
JMD 159.951556
JOD 0.708992
JPY 157.294501
KES 128.901985
KGS 87.449865
KHR 4003.445658
KMF 420.999696
KPW 899.985447
KRW 1478.840165
KWD 0.30732
KYD 0.83301
KZT 515.774122
LAK 21648.038141
LBP 89518.671881
LKR 309.300332
LRD 176.937412
LSL 16.761238
LTL 2.95274
LVL 0.60489
LYD 5.418406
MAD 9.162342
MDL 16.859064
MGA 4495.599072
MKD 52.551585
MMK 2099.831872
MNT 3551.409668
MOP 8.012145
MRU 39.906011
MUR 46.149573
MVR 15.459728
MWK 1733.41976
MXN 18.031765
MYR 4.077032
MZN 63.910399
NAD 16.761166
NGN 1457.903065
NIO 36.785119
NOK 10.18185
NPR 144.308882
NZD 1.74121
OMR 0.384499
PAB 0.999663
PEN 3.365814
PGK 4.308816
PHP 58.725048
PKR 280.102006
PLN 3.59715
PYG 6673.859367
QAR 3.645474
RON 4.3458
RSD 100.228971
RUB 80.525675
RWF 1455.461927
SAR 3.75079
SBD 8.140117
SCR 13.762717
SDG 601.497808
SEK 9.316225
SGD 1.292755
SHP 0.750259
SLE 24.096097
SLL 20969.503664
SOS 570.329558
SRD 38.67796
STD 20697.981008
STN 20.895879
SVC 8.747159
SYP 11057.107339
SZL 16.766099
THB 31.460123
TJS 9.231602
TMT 3.51
TND 2.921974
TOP 2.40776
TRY 42.80983
TTD 6.783
TWD 31.5475
TZS 2494.99991
UAH 42.222895
UGX 3571.01736
UYU 39.172541
UZS 12055.48851
VES 279.213402
VND 26312.5
VUV 121.400054
WST 2.789362
XAF 559.461142
XAG 0.015229
XAU 0.000231
XCD 2.70255
XCG 1.801636
XDR 0.695787
XOF 559.458756
XPF 101.714719
YER 238.450186
ZAR 16.77835
ZMK 9001.204375
ZMW 22.742295
ZWL 321.999592
  • VOD

    0.0950

    12.895

    +0.74%

  • RYCEF

    -0.1500

    15.25

    -0.98%

  • RBGPF

    0.0000

    80.22

    0%

  • BCC

    -2.1900

    75.51

    -2.9%

  • RIO

    0.6300

    78.26

    +0.81%

  • CMSC

    -0.0151

    23.3

    -0.06%

  • NGG

    -0.0700

    76.32

    -0.09%

  • JRI

    -0.0400

    13.39

    -0.3%

  • CMSD

    0.0800

    23.36

    +0.34%

  • RELX

    -0.0250

    40.625

    -0.06%

  • BCE

    0.1050

    22.955

    +0.46%

  • GSK

    0.2580

    48.548

    +0.53%

  • AZN

    0.7500

    91.36

    +0.82%

  • BTI

    -0.3800

    56.66

    -0.67%

  • BP

    0.5450

    33.855

    +1.61%

  • SCS

    0.0200

    16.14

    +0.12%

US researchers seek to legitimize AI mental health care
US researchers seek to legitimize AI mental health care / Photo: © GETTY IMAGES NORTH AMERICA/AFP/File

US researchers seek to legitimize AI mental health care

Researchers at Dartmouth College believe artificial intelligence can deliver reliable psychotherapy, distinguishing their work from the unproven and sometimes dubious mental health apps flooding today's market.

Text size:

Their application, Therabot, addresses the critical shortage of mental health professionals.

According to Nick Jacobson, an assistant professor of data science and psychiatry at Dartmouth, even multiplying the current number of therapists tenfold would leave too few to meet demand.

"We need something different to meet this large need," Jacobson told AFP.

The Dartmouth team recently published a clinical study demonstrating Therabot's effectiveness in helping people with anxiety, depression and eating disorders.

A new trial is planned to compare Therabot's results with conventional therapies.

The medical establishment appears receptive to such innovation.

Vaile Wright, senior director of health care innovation at the American Psychological Association (APA), described "a future where you will have an AI-generated chatbot rooted in science that is co-created by experts and developed for the purpose of addressing mental health."

Wright noted these applications "have a lot of promise, particularly if they are done responsibly and ethically," though she expressed concerns about potential harm to younger users.

Jacobson's team has so far dedicated close to six years to developing Therabot, with safety and effectiveness as primary goals.

Michael Heinz, psychiatrist and project co-leader, believes rushing for profit would compromise safety.

The Dartmouth team is prioritizing understanding how their digital therapist works and establishing trust.

They are also contemplating the creation of a nonprofit entity linked to Therabot to make digital therapy accessible to those who cannot afford conventional in-person help.

- Care or cash? -

With the cautious approach of its developers, Therabot could potentially be a standout in a marketplace of untested apps that claim to address loneliness, sadness and other issues.

According to Wright, many apps appear designed more to capture attention and generate revenue than improve mental health.

Such models keep people engaged by telling them what they want to hear, but young users often lack the savvy to realize they are being manipulated.

Darlene King, chair of the American Psychiatric Association's committee on mental health technology, acknowledged AI's potential for addressing mental health challenges but emphasizes the need for more information before determining true benefits and risks.

"There are still a lot of questions," King noted.

To minimize unexpected outcomes, the Therabot team went beyond mining therapy transcripts and training videos to fuel its AI app by manually creating simulated patient-caregiver conversations.

While the US Food and Drug Administration theoretically is responsible for regulating online mental health treatment, it does not certify medical devices or AI apps.

Instead, "the FDA may authorize their marketing after reviewing the appropriate pre-market submission," according to an agency spokesperson.

The FDA acknowledged that "digital mental health therapies have the potential to improve patient access to behavioral therapies."

- Therapist always in -

Herbert Bay, CEO of Earkick, defends his startup's AI therapist Panda as "super safe."

Bay says Earkick is conducting a clinical study of its digital therapist, which detects emotional crisis signs or suicidal ideation and sends help alerts.

"What happened with Character.AI couldn't happen with us," said Bay, referring to a Florida case in which a mother claims a chatbot relationship contributed to her 14-year-old son's death by suicide.

AI, for now, is suited more for day-to-day mental health support than life-shaking breakdowns, according to Bay.

"Calling your therapist at two in the morning is just not possible," but a therapy chatbot remains always available, Bay noted.

One user named Darren, who declined to provide his last name, found ChatGPT helpful in managing his traumatic stress disorder, despite the OpenAI assistant not being designed specifically for mental health.

"I feel like it's working for me," he said.

"I would recommend it to people who suffer from anxiety and are in distress."

F.Carrillo--TFWP